Infinite variety: the thin slices of tumor tissue samples already differ significantly, and not only on the outside. Major differences also exist under the microscope and in their molecular details.
All people are unique, and so are all diseases. The more doctors and biologists know about the differences between their patients, the more specifically they can treat their conditions. Individual codes inside our body's cells are increasingly helping doctors to precisely analyze patients. New diagnostic methods provide a detailed molecular profile and thus critical indicators for the best, personal therapy.
Good health is a molecular thing: in the future, a diagnosis will be supported by more than just an in-depth consultation with the patient, lab work and x-rays. Biomarkers may ultimately deliver the most crucial information on a patient's disease profile, thereby guaranteeing the more efficient use of modern medicine and, above all, improved therapeutic success for each and every patient. Using the methods of personalized medicine, Bayer researchers are working on new, targeted cancer treatments.